Acute Ischemic Stroke Associated With OrthoVisc (Hyaluronic Acid) Injection

Ben-Jiang Ma, Sampathkumar Shanmugham

Abstract


Hyaluronic acid (HA) is one of the main components of normal synovial fluid, acting as a shock absorber and a lubricant in the joints. When injected intra-articularly, the viscosupplementation of HA may potentially restore the biomechanical and biochemical functions of normal synovial fluid and may reduce the pain caused by osteoarthritis through anti-inflammatory, anabolic, analgesic, and chondroprotective mechanisms. HA has been approved by FDA as a medical device and has been used in patients with advanced osteoarthritis. Though it is usually safe and well tolerated, some local and systemic reactions can occur in rare cases. Here we report a 53-year-old man with severe osteoarthritis, who developed acute left cerebellar infarct after the injection of HA (OrthoVisc) preceded by symptoms of allergic reaction. Review of literature showed this is to date the first case of possible link between HA and ischemic stroke.




J Med Cases. 2017;8(7):219-223
doi: https://doi.org/10.14740/jmc2853w

Keywords


Hyaluronic acid; OrthoVisc; Ischemic stroke; Systemic reaction

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.